Jack Syage serves as Executive at First Wave BioPharma, Inc., where they oversee executive responsibilities. Since joining the company, Jack Syage has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 13, 2024 involved receiving (via award) 15,400 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 13, 2024 | FWBI | $0 | Award | 15,400 | $N/A | Discretionary |
Jack Syage currently holds 15,400 shares of First Wave BioPharma, Inc. (FWBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jack Syage has been a net neutral trader of FWBI stock. They have purchased $0 and sold $0 worth of shares.
Jack Syage's most recent insider trade was on Mar 13, 2024, when they sold 15,400 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted